Suchergebnisse - "Kaneto, H"

PubPharm (280)

1

Marked elevation of plasma procalcitonin levels in patients with diabetic ketoacidosis : A possible useful diagnostic biomarker

enthalten in: Diabetes & metabolism | 2020

von Anno, T. | Shigemoto, R. | Kawasaki, F. | +4

2

Association Between Severity of Diabetic Neuropathy and Success in Weight Loss During Hospitalization Among Japanese Patients with Type 2 Diabetes: A Retrospective Observational Study

in: Diabetes, Metabolic Syndrome and Obesity | 2020

von Nakanishi S | Hirukawa H | Shimoda M | +10

3

Decreased plasma aldosterone levels in patients with type 2diabetes mellitus : A possible pitfall in diagnosis of primary aldosteronism

enthalten in: Diabetes & metabolism | 2019

von Anno, T. | Mune, T. | Takai, M. | +6

4

Durability of protective effect of dulaglutide on pancreatic β-cells in diabetic mice : GLP-1 receptor expression is not reduced despite long-term dulaglutide exposure

enthalten in: Diabetes & metabolism | 2018

von Kimura, T. | Obata, A. | Shimoda, M. | +8

5

Increase in cortisol/ACTH ratio after chronic treatment with liraglutide in patients with type 2 diabetes

enthalten in: Diabetes & metabolism | 2017

von Kamei, S. | Kaneto, H. | Tanabe, A. | +11

6

Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes : The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)

enthalten in: Diabetes care | 2016

von Mita, T. | Katakami, N. | Yoshii, H. | +59

ErratumIn: Diabetes Care. 2017 Jun;40(6):808. - PMID 28420699

7

Low bilirubin levels are an independent risk factor for diabetic retinopathy and nephropathy in Japanese patients with type 2 diabetes

enthalten in: Diabetes & metabolism | 2015

von Hamamoto, S. | Kaneto, H. | Kamei, S. | +8

8

Low bilirubin levels are an independent risk factor for diabetic retinopathy and nephropathy in Japanese patients with type 2 diabetes

enthalten in: Diabetes & metabolism | 2015

von Hamamoto, S. | Kaneto, H. | Kamei, S. | +8

9

PO138 MOLECULAR MECHANISM FOR PROTECTIVE EFFECT OF PIOGLITAZONE AND LIRAGLUTIDE ON BETA-CELLS WITH THE PROGRESSION OF DIABETIC MORBIDITY

enthalten in: Diabetes research and clinical practice | 2014

von Kimura, T. | Shimoda, M. | Hirukawa, H. | +4

10

Rationale, design, and baseline characteristics of a trial for the prevention of diabetic atherosclerosis using a DPP-4 inhibitor : the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)

enthalten in: Journal of atherosclerosis and thrombosis | 2013

von Katakami, N. | Mita, T. | Yoshii, H. | +59

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[28]